McIlrath & Eck, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
McIlrath & Eck, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$7,000
+250.0%
31
+106.7%
0.00%
+100.0%
Q4 2020$2,000
+100.0%
150.0%0.00%
Q3 2020$1,000
-50.0%
150.0%0.00%
-100.0%
Q2 2020$2,000
+100.0%
150.0%0.00%0.0%
Q1 2020$1,000
-50.0%
150.0%0.00%0.0%
Q4 2019$2,0000.0%150.0%0.00%0.0%
Q3 2019$2,000150.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders